Ligand-Based Drug Design of Novel MARK-3 Inhibitors in Cancer

By  

Current Bioactive Compounds, Vol. 10, Iss. 2, 2014-07 ,pp. : 112-123

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of Novel CYP17 Inhibitors for the Treatment of Prostate Cancer with Structure-Based Drug Design

By  

Letters in Drug Design & Discovery, Vol. 6, Iss. 5, 2009-07 ,pp. : 337-344

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of HIV-1 Integrase Inhibitors through a Novel Combination of Ligand and Structure-based Drug Design

By  

Medicinal Chemistry, Vol. 1, Iss. 3, 2005-05 ,pp. : 263-275

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-Based Drug Design of Peptide Mimetics Containing Large P3 Moieties as Inhibitors of Factor VIIa

By  

Letters in Drug Design & Discovery, Vol. 6, Iss. 2, 2009-03 ,pp. : 86-92

Bentham Science Publishers

Access to resources Recommend Favorite

3-Phenyl-1H-Indole-5-Sulfonamides: Structure-Based Drug Design of a Promising Class of Carbonic Anhydrase Inhibitors

By  

Current Pharmaceutical Design, Vol. 16, Iss. 29, 2010-10 ,pp. : 3317-3326

Bentham Science Publishers

Access to resources Recommend Favorite